Related Experiment Video
Updated: Mar 22, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Management of novel oral anticoagulants in emergency and trauma surgery
Ana-Catarina Pinho-Gomes1, Adam Hague1, Jonathan Ghosh1
1Department of Vascular Surgery, University Hospital of South Manchester, UK.
Background:
The compelling safety, efficacy and predictable effect of novel oral anticoagulants (NOACs) is driving a rapid expansion in their therapeutic indications. Management of the increasing number of patients on those new agents in the setting of emergency or trauma surgery can be challenging and the absence of specific reversal agents has been a matter of concern. This review summarises the key principles that underpin the management of those patients with a particular emphasis on the recent development of specific antidotes.
Findings:
As of 2015, a new line of antidotes, specific for these drugs, are at different stages of their development with their release imminent. However, as NOACs are innately reversible due to their short half-life, the use of reversal agents will probably be restricted to a few exceptional cases. Post-marketing surveillance will be paramount to better clarify the role of these promising drugs.
Conclusions:
Management of patients on NOACs in the context of emergency or trauma surgery relies on best supportive care in combination with the blood products and/or specific antidotes as required. Familiarity with the new reversal agents is essential but further evidence on their indications, safety and efficacy as well as consensus guidelines are warranted prior to widespread adoption.
Insights
Novel oral anticoagulants (NOACs) are increasingly used, posing challenges in emergency surgery. While specific antidotes are emerging, their use will likely be limited, emphasizing supportive care and further research.
Area of Science:
- Pharmacology
- Emergency Medicine
- Surgical Management
Background:
- Novel oral anticoagulants (NOACs) demonstrate favorable safety and efficacy, leading to expanded therapeutic uses.
- Managing patients on NOACs during emergency or trauma surgery presents challenges due to the lack of specific reversal agents.
- This review focuses on management principles for patients on NOACs, highlighting the development of specific antidotes.
Purpose of the Study:
- To review management strategies for patients on novel oral anticoagulants (NOACs) undergoing emergency or trauma surgery.
- To emphasize the role and development of specific antidotes for NOACs.
- To discuss the implications of NOAC use in surgical settings.
Main Methods:
- Literature review of novel oral anticoagulants (NOACs) and their management in surgical emergencies.
- Analysis of the development status of specific reversal agents for NOACs.
- Synthesis of current best practices and emerging evidence.
Main Results:
- Specific antidotes for NOACs are nearing availability, though their use may be restricted to exceptional cases due to the drugs' short half-lives.
- NOACs are inherently reversible, suggesting supportive care remains a primary management strategy.
- Post-marketing surveillance is crucial for understanding the role of new reversal agents.
Conclusions:
- Management of patients on NOACs in emergency surgery involves supportive care, blood products, and potentially specific antidotes.
- Familiarity with new reversal agents is essential, but further evidence and guidelines are needed before widespread adoption.
- Ongoing research and consensus are required to optimize the use of NOAC reversal agents in clinical practice.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Aneurysm IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

